Skip to main content
Caplight Logo









Akita

Akita

Private
HelsinkiHealthcare & Life Scienceshttps://akita.bio/

Last Round

Grant

Oct 24, 2024

Total Funding Raised

$4.02M

Company Overview

Akita is a discovery tools (healthcare) company that develops microphysiological in vitro modeling systems designed for drug development and biomedical research purposes.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Biotech Equipment, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

organ-on-chiporgan chipmicrophysiological systemsMPSpreclinical testingdrug discoveryanimal testing alternativehigh-throughput screeningmicrofluidicsin-vitro testingtoxicology testingCRO servicescontract research organizationCROTEER measurementbiotech equipmentbody-on-a-chip

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Akita Comparables

Compare Akita with similar companies based on industry and business-model similarity.

Akita comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BIOND Solutions
88%
AlveoliX AG
88%
MIMETAS
87%

Akita Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantOct 24, 2024
SeedApr 13, 2022
SeedApr 29, 2020

Key People

Founding team and executive leadership

Jari Moilanen

COO

Executive Team

Akita Investors

Notable investors and investment history

Akita investors
InvestorRounds
Icebreaker.vcSeed
European CommissionGrant
Voima VenturesSeed
Takoa InvestSeed
AthensmedSeed
European UnionGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 18, 2026

    Monthly visitors increased 115% MoM, reaching 2.9K.

  • Jan 19, 2026

    Monthly visitors grew 100% MoM, reaching 1.3K.

Akita Filings

Explore SEC and related filing metadata, where available.

Akita filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Akita's valuation, stock price, and market status.

Is Akita a public or private company?

Akita is a private company.

What is the current stock price of Akita?

Akita is a private company with no public stock price. No recent secondary market data is available.

How much is Akita worth (valuation)?

Valuation information for Akita is not publicly available.

Can I buy Akita stock?

Akita shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Akita's last funding round?

Akita's most recent funding round was Grant on October 24, 2024.

Who are the main investors in Akita?

Key investors in Akita include Voima Ventures, Athensmed.

Will Akita IPO soon?

No public IPO plans have been announced for Akita.

How can I track Akita secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Akita's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHelsinki
Employee Range2
Year Founded2018
Last FundingOct 24, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?